LANSDOWNE PARTNERS (UK) LLP - Q3 2023 holdings

$1.09 Billion is the total value of LANSDOWNE PARTNERS (UK) LLP's 81 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .

 Value Shares↓ Weighting
NewCRH PLCord$145,937,8492,666,656
+100.0%
13.35%
AMZN NewAMAZON COM INC$60,662,951477,214
+100.0%
5.55%
BIDU NewBAIDU INCspon adr rep a$4,002,01829,788
+100.0%
0.37%
MNSO NewMINISO GROUP HLDG LTDsponsored ads$3,620,354139,782
+100.0%
0.33%
DADA NewDADA NEXUS LTDads$2,920,317656,251
+100.0%
0.27%
LI NewLI AUTO INCsponsored ads$2,751,96677,194
+100.0%
0.25%
LU NewLUFAX HOLDING LTD$2,138,0852,017,062
+100.0%
0.20%
HUYA NewHUYA INC$1,559,626549,164
+100.0%
0.14%
YSG NewYATSEN HLDG LTDads$1,216,8931,216,893
+100.0%
0.11%
RERE NewATRENEW INCsponsored ads$1,174,304515,046
+100.0%
0.11%
NewHESAI GROUPsponsored ads$870,02087,002
+100.0%
0.08%
ZLAB NewZAI LAB LTDadr$854,30235,142
+100.0%
0.08%
EH NewEHANG HLDGS LTDads$799,87244,388
+100.0%
0.07%
SYY NewSYSCO CORP$529,5238,017
+100.0%
0.05%
AEM NewAGNICO EAGLE MINES LTD$474,99810,451
+100.0%
0.04%
BNR NewBURNING ROCK BIOTECH LTDsponsored ads$118,915122,593
+100.0%
0.01%
ZH NewZHIHU INCads$22,09621,246
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DELTA AIR LINES INC DEL38Q3 202325.1%
EATON CORP PLC33Q3 202311.6%
TAIWAN SEMICONDUCTOR MFG LTD25Q3 202317.9%
MANCHESTER UTD PLC NEW22Q3 20191.0%
SUMMIT THERAPEUTICS PLC22Q2 20200.6%
AMAZON COM INC21Q3 202313.9%
JPMORGAN CHASE & CO20Q1 201919.9%
CITIGROUP INC20Q4 202012.2%
FIRST SOLAR INC20Q3 20214.2%
UNITED TECHNOLOGIES CORP20Q1 20203.7%

View LANSDOWNE PARTNERS (UK) LLP's complete holdings history.

Latest significant ownerships (13-D/G)
LANSDOWNE PARTNERS (UK) LLP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Supernova Partners Acquisition Co II, Ltd.February 14, 20222,152,9116.2%
Summit Therapeutics plcJune 17, 202013,664,8804.1%
Manchester United plcSold outFebruary 14, 202000.0%
CYTOKINETICS INCJanuary 30, 20182,647,9814.9%
RESPONSE GENETICS INCSold outFebruary 12, 201600.0%

View LANSDOWNE PARTNERS (UK) LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-10
SC 13G2023-02-08
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-16

View LANSDOWNE PARTNERS (UK) LLP's complete filings history.

Compare quarters

Export LANSDOWNE PARTNERS (UK) LLP's holdings